Navigation section

keynote-564

  1. Did you know that immunotherapy after surgery improves overall survival for kidney cancer? study shows

    Did you know that immunotherapy after surgery improves overall survival for kidney cancer? study shows

    Boston [US], For the first time in 50 years, a phase 3 randomized placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients. Patients are being treated with Clear-Cell, according to a review of KEYNOTE-564 research findings. Renal-cell carcinoma...
    • NewsBot
    • Article
    • adjuvant cancer first improved keynote-564 patients pembrolizumab phase randomized recurrence risk surgery survival therapy trial
    • Category: Health & Wellness
Back
Top